Two Upcoming Webinars

I like to highlight webinars or other educational events that I think will be useful to us, and the Lymphoma Research Foundation has a couple of events coming up that are worth highlighting.

The first one is happening next Tuesday (July 22) at 1:00pm Eastern. It's called "Understanding Immunotherapy for Lymphoma (CAR T-Cell Therapy, Bispecific Antibodies, & Antibody-Drug Conjugates)." The webinar will give an overview of Immunotherapies; discuss when Immunotherapies are appropriate; look at Clinical Trials; and give advice about managing side effects. There will be time for questions and answers.

The webinar will be run by two Lymphoma experts, Dr. Samuel Yamshon of Weill Cornell and Dr. Justin Kline of The University of Chicago.

You can register for the webinar here.  This isn't specific to Follicular Lymphoma, but it should give a good overview of some of the treatments that Follicular Lymphoma experts seem to be most excited about. 

A second LRF event is also not specifically about Follicular Lymphoma, but might also be useful to many of us.  It's called "Ask the Doctor About Lymphoma: Information for Relapsed/Refractory Patients," and it's happening Wednesday, July 30 from 4:00 to 6:00pm ET.

LRF's "Ask the Doctor" series is just what it sounds like. It begins with a presentation from a Lymphoma expert, giving information about a topic (in this case, Relapsed/Refractory Lymphoma, with a focus on symptoms, treatment options, and what to ask your health care team). But "Ask the Doctor" sessions are twice as long as the other webinars, and spend much more time on Questions and Answers. So this is an excellent opportunity to get specific information from an expert.

The expert who will presenting and answering questions is Dr. Boyu Hu of the University of Utah. You can register for the Ask the Doctor event here.

(And for those of you who have not yet had treatment, and feel like you're missing out, there's an Ask the Doctor event for you next month -- "Ask the Doctor About Lymphoma: Information for Newly Diagnosed Patients." Read more about it here.)

I hope you find this information useful. 

Keep learning and stay well.